Tenor Capital Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Tenor Capital Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.38K	Hold	250,000	–	–	﹤0.01%	523
2026 Q1	$5.47K	Hold	250,000	–	–	﹤0.01%	467
2025 Q4	$10K	Hold	250,000	–	–	﹤0.01%	391
2025 Q3	$19.9K	Hold	250,000	–	–	﹤0.01%	337
2025 Q2	$31.2K	Hold	250,000	–	–	﹤0.01%	288
2025 Q1	$35.8K	Hold	250,000	–	–	﹤0.01%	213
2024 Q4	$52.4K	Hold	250,000	–	–	﹤0.01%	186
2024 Q3	$50K	Hold	250,000	–	–	﹤0.01%	167
2024 Q2	$50K	Hold	250,000	–	–	﹤0.01%	173
2024 Q1	$45.5K	Hold	250,000	–	–	﹤0.01%	202
2023 Q4	$20K	Hold	250,000	–	–	﹤0.01%	211
2023 Q3	$12.5K	Hold	250,000	–	–	﹤0.01%	249
2023 Q2	$35K	Hold	250,000	–	–	﹤0.01%	224
2023 Q1	$50K	Hold	250,000	–	–	﹤0.01%	260
2022 Q4	$7.5K	Hold	250,000	–	–	﹤0.01%	447
2022 Q3	$15K	Hold	250,000	–	–	﹤0.01%	543
2022 Q2	$23K	Hold	250,000	–	–	﹤0.01%	573
2022 Q1	$65K	Hold	250,000	–	–	﹤0.01%	563
2021 Q4	$368K	Hold	250,000	–	–	0.01%	481
2021 Q3	$370K	Hold	250,000	–	–	0.01%	424
2021 Q2	$288K	Hold	250,000	–	–	0.01%	466
2021 Q1	$205K	Hold	250,000	–	–	0.01%	480
2020 Q4	$363K	Hold	250,000	–	–	0.01%	270
2020 Q3	$295K	Hold	250,000	–	–	0.01%	222
2020 Q2	$250K	Hold	250,000	–	–	0.01%	157
2020 Q1	$163K	Buy	+250,000	New	+$196K	0.01%	152

Other funds holding JSPRW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tenor Capital Management's JSPRW Position: Q2 2026 in Review

Tenor Capital Management held its Japer Therapeutics Warrants (JSPRW) position steady in Q2 2026 at 250,000 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

Tenor Capital Management first reported a position in JSPRW in Q1 2020 and has held it in 26 quarters since. The position peaked at $370K in Q3 2021. 6 funds tracked by Wall St. Rank hold JSPRW as of Q2 2026.

Tenor Capital Management held 250,000 shares of Japer Therapeutics Warrants worth $3.38K as of Q2 2026.
Tenor Capital Management left its Japer Therapeutics Warrants share count unchanged in Q2 2026.
Japer Therapeutics Warrants made up ﹤0.01% of Tenor Capital Management's portfolio in Q2 2026, its #523 holding.
Tenor Capital Management first reported a position in Japer Therapeutics Warrants in Q1 2020 and has held it in 26 quarters since.
Tenor Capital Management's Japer Therapeutics Warrants position peaked at $370K in Q3 2021.
6 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2026.

Based on Tenor Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.